// App-Quantinova.ai

967 : Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity in childhood asthma

Researchers

Presenter

  • Slob EMA

Principal Investigators

  • Vijverberg SJ

  • Longo C

  • Kutlu M

  • Soares P

  • Chew FT

  • Pino-Yanes M

  • Herrera-Luis E

  • Espuela Ortiz A

  • Burchard EG

  • Potocnik U

  • Palmer C

  • Maroteau C

  • Turner S

  • Verhamme K

  • Karimi L

  • Mukhopadhyay S

  • Timens W

  • Hiemstra P

  • Pijnenburg M

  • Van Den Berge M

  • Koppelman GH

Medical Centers

  • Department of Respiratory Medicine, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, Netherlands

  • Department of Paediatric Pulmonology, Amsterdam Public Health research institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

  • Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, Australia

  • Academic Department of Paediatrics, Brighton & Sussex Medical School, Royal Alexandra Children's Hospital, Brighton, United Kingdom

  • Department of Biological Science, National University of Singapore, Singapore, SingaporeResearch Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, Santa Cruz De Tenerife, Spain

  • Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, Santa Cruz de Tenerife, Spain,

  • CIBER de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III (ISCIII), Madrid, Spain

  • Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain

  • Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, Santa Cruz de Tenerife, Spain,

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

  • Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA

  • Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, SloveniaLaboratory for Biochemistry, Molecular Biology and Genomics, Faculty for Chemistry and Chemical Engineering, University of Maribor, Maribor, SloveniaPopulation Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Dundee, United Kingdom

  • University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, Netherlands

  • Hematology, Leiden University Medical Center, Leiden, The Netherlands,

  • Dept. of Pediatrics, Pediatric Pulmonology & Allergology, Erasmus Medical Center- Sophia Children’s Hospital, Rotterdam, Netherlands

  • University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, Netherlands

  • Dept. of Pediatric Pulmonology & Allergology, University Medical Center Groningen, GRIAC research Institute, Groningen, The Netherlands

Locations

  • Netherlands

  • Australia

  • United Kingdom

  • Spain

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A